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Abstract
We have identified and characterized a Macrophage Migration Inhibitory Factor (MIF) family member in the
Lophotrochozoan invertebrate, Biomphalaria glabrata, the snail intermediate host of the human blood fluke Schistosoma
mansoni. In mammals, MIF is a widely expressed pleiotropic cytokine with potent pro-inflammatory properties that controls
cell functions such as gene expression, proliferation or apoptosis. Here we show that the MIF protein from B. glabrata
(BgMIF) is expressed in circulating immune defense cells (hemocytes) of the snail as well as in the B. glabrata embryonic
(Bge) cell line that has hemocyte-like features. Recombinant BgMIF (rBgMIF) induced cell proliferation and inhibited NO-
dependent p53-mediated apoptosis in Bge cells. Moreover, knock-down of BgMIF expression in Bge cells interfered with the
in vitro encapsulation of S. mansoni sporocysts. Furthermore, the in vivo knock-down of BgMIF prevented the changes in
circulating hemocyte populations that occur in response to an infection by S. mansoni miracidia and led to a significant
increase in the parasite burden of the snails. These results provide the first functional evidence that a MIF ortholog is
involved in an invertebrate immune response towards a parasitic infection and highlight the importance of cytokines in
invertebrate-parasite interactions.
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Introduction
Schistosomiasis, the second most widespread human parasitic
disease after malaria [1], is caused by helminth parasites of the
genus Schistosoma and more than 200 million people in 74 countries
suffer from the pathological consequences of this disease [2].
Human infection requires contact with freshwater in which
infected snails (the intermediate hosts of schistosomes) have
released cercariae larvae that penetrate human skin. The complex
interaction between the intermediate snail host and the parasite
and in particular between Schistosoma mansoni and the snail
generally used for its laboratory maintenance, Biomphalaria glabrata,
is of interest both in terms of transmission dynamics, but
increasingly as a model for the study of the innate immune
response and its evolution.
In order to protect themselves against pathogens, invertebrates
use innate immune responses such as wound repair, coagulation,
phagocytosis and encapsulation reactions, also used by vertebrates
[3]. Major signalling pathways or effector molecules underlying
innate immune responses of vertebrates and invertebrates are
also shared, as for instance the Toll receptors described for
the first time in Drosophila [4] or members of immunoglobulin
superfamily such as the FREPs (Fibrinogen-RElated Proteins) in
B. glabrata [5].
The need for regulation of cellular immunity and the parallels
made between vertebrate and invertebrate innate immunity led to
an intense search for invertebrate cytokines [6]. Cytokines specific
to invertebrates, such as spa¨tzle in Drosophila [4], astakine in
Pacifastacus leniusculus [7], or CCF in Eisenia foetida [8] have been
described, but to date, only very few orthologs of vertebrate
cytokines have been incontrovertibly identified in invertebrates
[9], one of which is Macrophage Migration Inhibitory Factor
(MIF). MIF was one of the first mammalian cytokines to be
discovered and has been described as a pivotal regulator of innate
immune and inflammatory responses in mammals [10]. It was first
characterized as a factor derived from activated T cells that
inhibited random migration of macrophages [11], [12]. Since the
first cloning of a MIF gene [13] many biological activities have
been described, including stimulation of cell proliferation through
ERK1/ERK2 pathway activation, activation of the response
against endotoxin or Gram negative bacteria by upregulation of
TLR4 (the signal-transducing molecule of the LPS receptor
complex) expression and the suppression of p53-mediated growth
arrest in macrophages challenged by LPS [10]. In addition MIF
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possesses intrinsic tautomerase activity (keto-enol isomerisation of
small aromatic substrates such as L-dopachrome methyl ester) that
is dependent on the post-translational cleavage of the initiating
methionine to expose an N-terminal proline residue [14].
Interestingly, MIFs have been characterized in a wide variety of
parasites, including nematodes and protozoans [15], [16] but the
role of the cytokine has been mainly studied in the context of the
host-parasite relationship with the emphasis on the effect of
parasite MIF on the host immune response. For instance
Ancylostoma MIF has been shown to bind to the human MIF
receptor [17] and recombinant Brugia MIF induces the release of
cytokines (IL-8, TNFa) from human macrophages [18]. Similarly,
Plasmodium MIF is thought to influence the host immune response
and the course of anemia during infection [16]. MIFs have also
recently been identified in two species of mollusks, disk abalones
[19], but currently, nothing is known about the role of MIF from
the invertebrate host during an immune response to a pathogen.
Strikingly, an exhaustive search of the S. mansoni genomic
sequences (AB-G, unpublished) failed to find any MIF signature
sequences These in silico findings are consistent with the in vitro
work of others describing the absence of MIF homologs in
parasitic trematodes [20].
The discovery in B. glabrata of a potential cytokine-like molecule
displaying significant sequence similarity to MIF [21], raised the
question of its potential involvement in the regulation of the snail
immune response to parasite infection. In this report, we
demonstrate that the MIF protein from B. glabrata (BgMIF) is
expressed in circulating immune defense cells (hemocytes) of the
snail as well as in the B. glabrata embryonic (Bge) cell line that has
hemocyte-like features. We show that recombinant BgMIF
(rBgMIF) possesses the conserved tautomerase enzymatic activity
of the MIF family, induces cell proliferation (correlating with ERK
phosphorylation) and inhibits NO-dependent, p53-mediated
apoptosis in Bge cells. Moreover, knock-down of BgMIF in Bge
cells inhibits the in vitro encapsulation of S. mansoni sporocysts and
this correlates with an inhibition of p38 phosphorylation in these
cells. Finally, in whole snails, we demonstrate the involvement of
BgMIF in the snail anti-parasitic response towards S. mansoni.
Furthermore, the tools developed here pave the way toward a
better understanding of the complex interactions between S.
mansoni and its molluscan snail host.
Results
The freshwater snail B. glabrata expresses a MIF ortholog
with tautomerase activity
Alignment of MIF peptide sequences (Figure 1A) shows that
BgMIF contains the N-terminal catalytic proline (Pro2) that is
exposed by cleavage of the initiating methionine and is essential
for tautomerase activity (see below and [14]). With 31% sequence
identity to human MIF, BgMIF is less conserved than MIFs from
two other mollusks, the bivalve abalones, Haliotis diversicolor sextus
(39%) and Haliotis discus discus (35%). Several invariant active site
residues [15] are conserved, including Lys32 and Ile64. The
conserved Val106 residue is substituted by a Cys in BgMIF or by
Leu in MIF from Ixodes scapularis, thus maintaining the presence of
a hydrophobic residue at this position (Figure 1A). To further
investigate the relationship between BgMIF and other MIFs, we
performed a phylogenetic analysis (using two different analyses
with similar results: see Methods) on selected vertebrate and
invertebrate proteins (Figure 1B). The phylogeny of selected MIFs
proved to be complex with numerous small clades and no strong
relationship with taxonomy. Although BgMIF is clearly grouped in
the phylogenetic tree with nematode MIF2 sequences [15], it is not
closely related to other mollusk MIFs (Figure 1B).
A hallmark of all MIF family members is the enzymatic
tautomerase activity; we expressed it as a recombinant protein
(rBgMIF) in E. coli together with a site-directed mutant
(rBgMIFP2G), in which the N-terminal Proline (Pro2) was
substituted by Gly. We used rBgMIF and rBgMIFP2G to perform
a tautomerase assay with mouse MIF (rMmMIF) as a positive
control and L-dopachrome methyl ester as a substrate. The results
(Figure 2) showed that rBgMIF displayed tautomerase activity
comparable to that of the mouse MIF protein and that, as
expected; the mutant rBgMIFP2G did not have any detectable
activity. Therefore, as in all MIF family members, Pro2 is required
for enzymatic activity of BgMIF. In addition we tested the
inhibition of the tautomerase activity using the MIF antagonist
ISO-1 a specific inhibitor of mammalian MIF [22]. rBgMIF
treated with 100 or 200 mM of ISO-1 (Supplementary data Fig S1)
was inhibited by more than 95% at both doses.
BgMIF is expressed by snail immune defense cells and
secreted in the hemolymph
In contrast to most cytokines, MIF is constitutively expressed
and stored in intracellular pools. MIF secretion is induced by
inflammatory stimuli such as endotoxin (LPS) or tumor necrosis
factor (TNF-a), as well as by hormones [10]. MIF is expressed by
defense cells such as macrophages [23], monocytes, neutrophils,
dendritic cells and other cell types in tissues in contact with the
host’s natural environment [10]. We examined tissue specific
expression of MIF in B. glabrata snails by western blotting of
protein extracts from various snail organs using an antiserum
raised against two peptides derived from the BgMIF sequence.
This antiserum was shown to recognize native BgMIF (Figure 3A).
A single band corresponding to BgMIF was found in all tissues
tested, including the albumen gland, digestive tract, heart
(hematopoietic organ) hepatopancreas, and foot (Figure 3A). In
order to confirm the presence of BgMIF in B. glabrata hemocytes,
we performed both western blotting and immunolocalisation
analyses. BgMIF was detected in hemocyte lysates (Figure 3A) and
immunolocalized in the cytoplasm of hemocytes. BgMIF was
found to be more abundant in well spread hemocytes, termed
granulocytes, than in unspread hemocytes or hyalinocytes [24],
[25] (Figure 3B–D).
Author Summary
Schistosoma mansoni, a parasitic blood fluke that causes
intestinal schistosomiasis in humans, requires an interme-
diate host, a freshwater snail of the genus Biomphalaria for
its transmission. Infection of the snail triggers marked
cellular and humoral immune responses, but the molecular
mechanisms of these responses are not well known. We
have identified and characterized the involvement of a
snail homologue of the cytokine MIF (Macrophage
Migration Inhibitory Factor) in the snail immune responses
to infection by the parasite. By using biochemical and
molecular approaches in combination with in vitro culture
and in vivo gene knock down, we have demonstrated the
role of snail MIF in the regulation of the snail innate
immune system. In particular, MIF regulates the prolifer-
ation and activation of the hemocytes, the macrophage-
like snail defense cells, and the encapsulation response.
This shows for the first time that MIF has a conserved
cytokine function in an invertebrate and underlines the
interest of the schistosome-snail model in the study of
innate immunity.
MIF Regulates the Snail Innate Immune Response
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Figure 1. BgMIF is a variant member of the MIF family. (A) Alignment of the BgMIF (BgMIF; accession number: ACR81564) peptide sequence to
MIFs from Haliotis discus discus (HddMIF; accession number: FJ435176), Haliotis diversicolor sextus (HdsMIF; EU284114), Ixodes scapularis (IsMIF;
EEC11419), Petromyzon marinus (PmMIF; accession number: AA833793) and Homo sapiens (HsMIF; accession number: NM_002415). Residues
conserved in the tautomerase catalytic site are marked with a star. Putative protein secondary structure (a= a-helix, b=b-sheet) according to (11) is
shown above the sequence alignment. (B) Maximum-likelihood tree of BgMIF and MIF proteins from selected species (Genbank accession numbers
and name of species are shown on the tree). The tree obtained using MrBayes is shown (see methods). Numbers above branches are Bayesian
Posterior Probability values (100000 replicates). Horizontal distances are proportional to percents of divergence between tip species and nodes (scale
given), vertical distances are arbitrary. Only BPP values .0.5 are shown. M, Mollusks; N, Nematodes; P, Protozoans; V, Vertebrates.
doi:10.1371/journal.ppat.1001115.g001
MIF Regulates the Snail Innate Immune Response
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ELISA tests performed with anti-BgMIF serum allowed us to
detect BgMIF in plasma (cell-free hemolymph) and to demonstrate
that the amount of BgMIF in plasma progressively decreased
during infection by S. mansoni (34% of decrease at 48 h post-
infection) (Supplementary data Figure S2).
BgMIF is expressed and secreted in the Bge cell line
Bge cells represent the only existing molluscan cell line and
display hemocyte-like immune functions [26]. They have previ-
ously been described to share with hemocytes a fibroblastic origin
and the ability to recognize and phagocyte or encapsulate foreign
material including larval trematodes [26], [27]. In order to assess
the pertinence of this cell line as an in vitro system for the analysis of
BgMIF activity and function, we first searched for the presence of
BgMIF in Bge cells. BgMIF was readily detectable in these cells by
western blotting (Figure 3A) and immunolocalization showed that,
as in hemocytes, BgMIF could be detected in the Bge cell
cytoplasm (Figure 3E–G). In order to determine whether Bge cells
could also release BgMIF protein upon immune stimulation, as
observed in vitro for mammalian macrophages [23], we cultured
Bge cells in the presence of S. mansoni excretory-secretory products
(ESP) that have been shown to modulate gene expression in these
cells [28]. BgMIF secretion was induced by ESP at 30 mg/mL
(protein) with an apparent maximum at a dose of 120 mg/mL
(Figure 3H).
We have also carried out a western blot of ESP from sporocysts
with the anti-BgMIF antiserum and as expected in view of the
absence of MIF signature sequences from the S. mansoni genome,
no cross-reactive bands were detected (data not shown).
rBgMIF stimulates cell proliferation by sustained
activation of ERK in Bge cells
In mammals, MIF stimulates the proliferation of quiescent
fibroblasts in an ‘‘ERK sustained activation’’ dependent manner
[29]. We determined whether BgMIF promotes cell proliferation
by stimulating quiescent Bge cells with rBgMIF for 24 h and
measuring BrdU incorporation. Purified rBgMIF stimulated cell
proliferation in a dose dependent manner from a concentration of
50 ng/ml, with a maximum incorporation rate at 100 ng/ml
(Figure 4A).
ERK-MAPK pathway activation is associated with mammalian
MIF induced cell proliferation. To investigate whether BgMIF
activated ERK, quiescent Bge cells were treated with rBgMIF and
the cell lysates examined for ERK phosphorylation by Western
blot analysis using phospho-specific anti-ERK antibodies. MIF
induced phosphorylation of a B. glabrata ERK homolog in a dose
and time-dependent fashion (Figure 4B). ERK phosphorylation
was detected as early as 2 h and was sustained for at least 24 h as
previously described for ERK in the NIH/3T3 fibroblast cell line
(Figure 4B) [29]. In addition, U0126 the specific inhibitor of MEK
(mitogen-activated protein kinase/ERK kinase), the upstream
kinase of ERK [30], prevented the stimulatory effect of BgMIF on
Bge cell proliferation (Supplementary data Figure S3) and ERK
phosphorylation (data not shown), further indicating that MIF can
induce proliferation via the ERK1/ERK2 pathway.
rBgMIF suppresses NO induced apoptosis in Bge cells
MIF was found to inhibit NO-induced intracellular accumula-
tion of p53 and, therefore, p53-mediated apoptosis in macro-
phages [31]. To investigate whether BgMIF inhibits apoptosis
induced by NO accumulation, Bge cells were treated with the NO
donor SNGO and different concentrations of rBgMIF. The
proportion of apoptotic cells, labeled by the TUNEL method, was
quantified using FACS analysis. As in mammalian macrophages,
SNGO induced a significant level of apoptosis in Bge cells that was
decreased in a dose-dependent manner by the addition of BgMIF
(Figure 5A) and except for the lowest concentration of rBgMIF
(25 ng/ml), the decrease in the percentage of apoptotic cells was
statistically significant (Figure 5B). In mammalian macrophages, it
has been shown that NO treatment is associated with a coordinate
increase in the phosphorylation of p53 on Ser15, and that
immunoblotting for phosphorylated p53 is a sensitive way of
Figure 2. D-dopachrome tautomerase activity. Analysis of the D-dopachrome tautomerase enzymatic activity measured by loss in absorbance
at 475 nm and plotted against the concentration of 2-carboxymethylester-2,3-dihydroindole-5,6-quinone for 50 nM wild type rBgMIF and mutated
rBgMIF P2G. MmMIF at the same concentration was used as a positive control. Results shown are the means +/2 S.D. of three independent
experiments.
doi:10.1371/journal.ppat.1001115.g002
MIF Regulates the Snail Innate Immune Response
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Figure 3. Expression of BgMIF. (A) BgMIF is detectable in various snail tissues. Western blotting using an antiserum directed against a peptide
derived from BgMIF detects the protein as a single band in whole snails (WS), albumen gland (AG), digestive tract (DT), heart (H), hepatopancreas
(HP), and foot (F), as well as in hemocytes (HC) and Bge cells (Bge). (B–D) Immunolocalization of BgMIF in hemocytes. Hemocytes were labeled with
phalloidin (actin label) and Hoechst (B), with anti-BgMIF and Hoechst (C) or all three labels (D). Note that BgMIF labeling is much less visible in two
unspread hemocytes (white arrows) compared to spread hemocytes exhibiting pseudopods (red arrows). Scale bar represents 12 mm. (E–G)
Immunolocalization of BgMIF in Bge cells. Cells were labeled with phalloidin (actin label) and Hoechst (E), with anti-BgMIF and Hoechst (F) or all three
labels (G). Scale bar represents 12 mm. (H) Immunoblotting of Bge cell culture supernatants with anti-BgMIF antibody. Cells were exposed to
increasing concentrations of S. mansoni ESP (30–480 mg/mL).
doi:10.1371/journal.ppat.1001115.g003
MIF Regulates the Snail Innate Immune Response
PLoS Pathogens | www.plospathogens.org 5 September 2010 | Volume 6 | Issue 9 | e1001115
detecting the influence of MIF on intracellular p53 [31].
Examination of B. glabrata ESTs and genome sequences have
allowed us to characterize a p53 ortholog (GenBank accession
number: GU929337). We therefore examined whether inhibition
of apoptosis in Bge cells treated with rBgMIF could be related to a
decrease in NO-induced p53 accumulation in these cells. Western
blot analysis of cell lysates using a phospho-specific (Ser15) anti
p53 antibody showed that rBgMIF inhibited p53 phosphorylation
in Bge cells and suggested that this mechanism participated in the
suppression by rBgMIF of NO-induced apoptosis (Figure 5C).
BgMIF promotes S. mansoni sporocyst encapsulation in
vitro
We have demonstrated that Bge cells secrete BgMIF when they
are incubated with S. mansoni ESP (Figure 3H). In these
experiments, we additionally observed that Bge cells aggregated
and changed their form upon ESP induction (Figure 6A Ctrl+ESP)
like mammalian macrophages induced by LPS [32], nevertheless
this phenotype had not previously been described for B. glabrata
cells and was not due to contaminating endotoxin in the ESP
preparation (see Methods). In order to determine whether this
aggregative behavior was regulated by BgMIF, we used RNAi to
knock-down (KD) its expression in Bge cells, using dsRNA against
BgMIF (dsMIF) or dsRNA against luciferase (dsLuc) as an
unrelated control. The efficiency of BgMIF KD was confirmed
by the marked decrease (70%) of BgMIF transcripts observed after
a 3 day incubation with dsMIF, as compared to incubation with
dsLuc (Figure 7A). When S. mansoni ESP (120 mg/mL) was added
to cells treated with dsRNA, aggregation was observed in dsLuc
(Figure 6B dsLuc+ESP) but not in dsMIF treated cells, which
remained well-individualized, with numerous round and unspread
refringent cells (Figure 6B dsMIF+ESP), suggesting that BgMIF is
involved in the regulation of Bge cell activation induced by
parasites. S. mansoni ESP have been shown to stimulate the p38
MAPK signaling pathway in Bge cells [33] manifested by the
phosphorylation of Bgp38. We therefore tested the increase in
phosphorylation of Bgp38 in response to the incubation with ESP.
We detected a rapid activation of Bgp38 after 15 min in dsLuc
treated cells, while in dsMIF treated cells p38 was not activated
(Figure 6C).
We next determined the effect of BgMIF-induced cell activation
using the in vitro model of S. mansoni sporocyst encapsulation by Bge
cells [27], [34]. To Bge cells treated with dsMIF or dsLuc for 72 h,
we added 48 h in vitro-transformed sporocysts and followed
interaction of Bge cells with sporocysts for a further 72 h. Control
(as well as dsLuc treated) Bge cells (Figure 8A) readily migrated
towards and encapsulated the sporocysts as previously observed
Figure 4. rBgMIF stimulates the proliferation and sustained activation of ERK in Bge cells. (A) Bge cell proliferation rate after exposure to
various concentrations of rBgMIF. Proliferation was assessed using BrdU incorporation measured by an ELISA assay. Results are represented as fold
increase in BrdU incorporation as compared to incorporation in control cells. The results shown are the mean 6 SD of two assays carried out in
quadruplicate and are representative of 3 separate experiments *p,0,05. (B) Immunoblotting of cell lysates using an anti-phosphorylated ERK 1/2
antibody (P-ERK) and an anti-ERK 1/2 antibody for control of total ERK content (total ERK).
doi:10.1371/journal.ppat.1001115.g004
MIF Regulates the Snail Innate Immune Response
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Figure 5. rBgMIF suppresses NO induced apoptosis in Bge cells. (A) Cells treated or not with the NO-donor SNGO were fixed and submitted
to a TUNEL assay. The positively stained cells were quantified by FACS. (B) The FACS data are displayed as the percentage of cells undergoing
apoptosis, i.e. cells within the limits of fluorescence shown in (A). Results are the mean 6 SD of 3 separate experiments (*p,0.05). (C)
Immunoblotting of cell lysates using an anti-p53ser15P antibody (p53P15) and an anti-actin antibody to control for protein content in each sample.
doi:10.1371/journal.ppat.1001115.g005
MIF Regulates the Snail Innate Immune Response
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[34] but dsMIF-treated cells showed a markedly reduced ability to
encapsulate the sporocysts (Figure 8A). The proportion of
encapsulated sporocysts was indeed significantly reduced
(p,0.05) in dsMIF treated Bge cells compared to dsLuc treated
cells or untreated control cells (Figure 8B).
BgMIF is implicated in hemocyte activation in response
to parasitic infection in vivo
Since BgMIF promotes cellular responses to immune stimula-
tion in vitro, we examined its role in the activation of hemocytes in
B. glabrata snails confronting a parasitic infection. We first analyzed
the circulating hemocyte population in non-infected versus
infected snails, using flow cytometry based mainly on size (forward
scatter-FSC) and granularity (side scatter-SSC) dot plot distribu-
tion. In non-infected snails the content of circulating hemocytes
was shown to be very heterogeneous and we could discriminate
two subpopulations, R1 (small and medium hemocytes) and R2
(large hemocytes) (Figure 9A). 24 h following infection, the
population of circulating hemocytes showed a marked reduction
in the R2 subpopulation of large cells or granulocytes (Figure 9A),
which together with hyalinocytes, make up the heterogenous cell
population present in healthy snails [25]. This decrease in
circulating granulocytes is linked to their migration toward the
tissues invaded by miracidia [35], [36].
In order to determine whether these cellular changes were
regulated by BgMIF, we performed RNAi KD in whole snails by
microinjecting 15 mg dsMIF or dsLuc into the cardiac sinus. BgMIF
expression was monitored three days after dsRNA injection. We
observed a decrease in BgMIF transcripts and protein in both whole
snails and circulating hemocytes (Figure 7B–7C) treated with
dsMIF, as compared to dsLuc treated animals. Next we infected
control and dsMIF or dsLuc-treated snails by S. mansoni miracidia
and analyzed the circulating hemocyte content 24 h after infection.
Compared to dsLuc controls, dsMIF-treated infected snails
exhibited a hemocyte profile similar to that found in non-infected
snails (Figure 9B). These results corroborated the data obtained in
vitro with Bge cells and further supported a role for BgMIF in the
hemocyte response during a parasite infection of B. glabrata.
Figure 6. BgMIF promotes an aggregative phenotype and Bgp38 activation induced by ESP. (A) Effect of S. mansoni ESP (120 mg/mL) on
the aggregative behavior of Bge cells. Cells incubated in the absence of ESP have a uniform distribution but cells incubated with ESP are clumped and
their shape had changed. (B) Effect of S. mansoni ESP (120 mg/mL) on the aggregative behavior of Bge cells exposed to Luc (dsLuc) or BgMIF (dsMIF)
dsRNA for 3 days and subsequently incubated or not with 120 mg/mL of sporocyst ESPs. Cells treated with dsLuc show normal aggregative behavior
in the presence of ESP whereas those treated with dsMIF no longer aggregate in the presence of ESP. Note that the same number of Bge cells (26105)
was used in each case. Scale bar represents 100 mm. (C) Effect of S. mansoni ESP (120 mg/mL) on the activation (phosphorylation) of Bgp38 of dsRNA
treated Bge cells.
doi:10.1371/journal.ppat.1001115.g006
MIF Regulates the Snail Innate Immune Response
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Finally, we tested the effect of BgMIF silencing of the snails on the
level of infection observed with S. mansoni miracidia. We observed
that dsMIF treated snails have significantly more parasites than
dsLuc treated and control, untreated snails (Figure 10). These results
further show that BgMIF is essential for the control of the immune
response of snail against parasite infection.
Discussion
Invertebrate immune systems have now become a major
research focus for investigating broader questions such as the
diversity of immune responses including those against parasitic
and viral infections [37], [38], processes involved in the immunity
of lophotrochozoan invertebrates, or the question of cytokine-
dependent regulatory processes [9], [39]. Here we investigated the
role of MIF, a putative ortholog of the vertebrate cytokine in the
immune response of a lophotrochozoan invertebrate, the gastro-
pod Biomphalaria glabrata towards its natural parasite Schistosoma
mansoni.
The BgMIF protein sequence shares sequence and structural
homologies with other members of the MIF family, including
Figure 7. RNAi efficacy in Bge cells, whole snails and hemocytes. (A) Relative expression ratios of BgMIF transcripts and BgMIF protein in Bge
cells exposed for 3 days to Luc (dsLuc) or BgMIF (dsMIF) dsRNA. Transcript levels were determined using real-time quantitative PCR (Methods) and
protein levels of BgMIF and actin were determined by western blotting (B–C) Relative expression ratios of BgMIF transcripts and BgMIF protein in
whole snails and in their hemocytes (Hc) exposed for 3 days to Luc (dsLuc) or BgMIF (dsMIF) dsRNA. Transcript levels were determined using real-time
quantitative PCR (Methods) and protein levels of BgMIF and actin were determined by western blotting.
doi:10.1371/journal.ppat.1001115.g007
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residues that are invariant across the whole MIF family (Asp9, Pro
56 and Leu88), or involved in the tautomerase enzymatic activity
(Pro2, Lys32, Ile64). In addition, analysis of the secondary
structure shows that the BgMIF protein is composed of four a-
helices and four b-sheets as for other MIF family members. Results
obtained with the recombinant BgMIF proteins indicated that
BgMIF has a conserved dopachrome tautomerase enzyme activity
dependent on the Pro2 residue and the results obtained with ISO-
1, which interacts with the catalytic active site residues of
mammalian MIF [22], show that the catalytic active site of
BgMIF is conserved (even though residues Tyr 95 and Asp 97 in
human MIF are respectively Val (as in the tick I. scapularis,
Figure 1A) and Lys (as in the abalone MIFs) in BgMIF). The
requirement for the enzymatic activity of MIF proteins for their
Figure 8. BgMIF is essential to promote in vitro encapsulation of S. mansoni sporocysts. (A) Encapsulation response of Bge cells in the
presence of in vitro transformed S. mansoni sporocysts. Cells were exposed to Luc (dsLuc) or BgMIF (dsMIF) dsRNA. Sporocysts are indicated with an
arrow. Note that, in the dsMIF culture, the sporocyst tegument remained easily visible and free of cells whereas in the control cultures, sporocysts
became uniformly covered with Bge cells. (B) Quantification of sporocysts encapsulated by dsRNA-treated or untreated Bge cells. Sporocysts were
deemed not to be encapsulated if Bge cells were found adhering to less than 10% of their surface. Scale bar represents 10 mm. The results are
expressed as the percentage of sporocysts that were encapsulated and are the mean 6 SD of three independent experiments.
doi:10.1371/journal.ppat.1001115.g008
Figure 9. BgMIF is implicated in hemocyte activation in response to parasitic infection in vivo. (A) Profile of circulating hemocyte
populations in non-infected or infected B. glabrata 24 h after infection with 15 S. mansonimiracidia. Two major hemocyte subpopulations (R1 = small
and medium and R2= large) can be identified by flow cytometric dot plot distribution based on laser forward scatter (FSC) versus laser side scatter
(SSC). Mean percentages of the R2 population +/2 S.D. in three separate experiments is shown. (B) Effect of S. mansoni infection on the circulating
hemocyte populations of dsLuc or dsMIF treated snails. Mean percentages of the R2 population +/2 S.D. in three separate experiments is shown.
*designates values that differ significantly from the R2 population of non infected snails (p,0.05).
doi:10.1371/journal.ppat.1001115.g009
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biological activity has not been established and the use of a
tautomerase-null MIF gene knock-in mouse model indicated that it
was not involved in the growth-regulatory activity of the cytokine
[40]. However, it does appear that the catalytic site could be
important for pro-inflammatory activity, but the reason for this is
still unknown. One possibility is that the catalytic site of MIF
affects its binding to the MIF receptor, CD74, and its activation
[41]. It has also been suggested that the tautomerase activity may
be a vestige of a role in the invertebrate melanotic encapsulation
response against microbial invasion, reflecting an ancestral role of
the protein in the innate immune response [42]. In the context of
BgMIF the significance of this tautomerase activity remains
unknown as is the hypothetical interaction of the catalytic site
with an as yet uncharacterized BgMIF receptor. On the other
hand, the immunological relevance of this activity does not seem
to be related to melanotic encapsulation, since melanization has
not been described for B. glabrata.
In contrast to most cytokines, MIF is constitutively expressed
and stored in intracellular pools and does therefore not require de
novo protein synthesis before release into the extracellular milieu.
These features provide MIF with the capacity to be released
immediately and to act as an effector molecule regulating innate
immunity [10]. Macrophages, which represent the first cellular
barrier of defense towards pathogen invasion, are an important
source of MIF protein, but MIF is also expressed in the tissues that
are in contact with the host’s natural environment. In this study we
showed that BgMIF protein was constitutively present in all the
snail tissues tested. In addition we found BgMIF protein in the
cytoplasm of hemocytes. It was more abundant in the granulocytic
forms that are involved in defence responses including phagocy-
tosis or encapsulation of pathogens, than in the cytoplasm of
hyalinocytes. In addition we have demonstrated the presence of
BgMIF protein in the plasma of snails and its decrease after
infection by S. mansoni. This decrease correlates with the migration
of granulocytes towards infected tissues. We further found BgMIF
protein in the cytoplasm of Bge cells that share hemocyte
characteristics. Bge cells also secreted BgMIF protein in the
presence of Schistosoma released products, thus validating the use of
these cells in the bio-assays we developed to assess the biological
activities of recombinant BgMIF.
When they enter B. glabrata snails, S. mansoni miracidia are
readily located by the hemocytes and trigger marked cellular and
humoral responses involving both migration of hemocytes toward
the site of infection and an increase in hemocyte production [43].
In addition, reactive nitrogen and oxygen species (RNS and ROS)
produced by the hemocytes can damage miracidia/newly-
transformed sporocysts [38], but at the same time they can also
induce hemocyte apoptosis. Important biological activities of MIF
Figure 10. BgMIF controls the infectivity of S.mansoni. Effect of knockdown of BgMIF on S. mansoni infectivity. Snails were injected with both
dsLuc or dsMIF dsRNA and 72 h later, were infected with 20 miracidia. 15 days after infection snails were fixed in Raillet–Henry’s solution and
dissected and visually inspected to detect mother sporocysts (Sp1). Results from two independent experiments are shown. *(p,0.05) or ** (p,0.01)
designates values that differ significantly in the dsMIF injected snails compared to dsLuc injected or untreated (Ctrl) snails.
doi:10.1371/journal.ppat.1001115.g010
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are likely to play a key role in this immune response, including the
activation of MAPK such as ERK1/2 and the inhibition of p53-
mediated apoptosis [10]. Although the MAPK pathways have only
been partially characterized in mollusks, previous studies on
B. glabrata have documented the involvement of ERK1/2 and
other MAPK family members in signaling events leading to
cellular immune responses in this snail [33], [44], [45], [46]. Using
Bge cells as an in vitro model, we demonstrate in this work the
induction of cell proliferation by rBgMIF in a dose-dependent
manner. This proliferation was correlated with an increase in
phosphorylated ERK in Bge cells as early as 2 h that was sustained
for at least 24 h. This activity seems directly linked to the
proliferation of the defense cells in response to immune stimulation.
The inhibition of NO-induced intracellular p53, which in turn
inhibits apoptosis, is a well-documented effect of mammalian MIF
that leads to a sustained proinflammatory function in macrophages
exposed to LPS [31]. We showed that incubation with rBgMIF
significantly reduced the apoptotic response of Bge cells, induced
by SNGO as an NO-donor. The inhibition of apoptosis was
accompanied by a reduction in the amount of phosphorylated
Bgp53, the p53 ortholog recently identified in B. glabrata snails.
These data further support the conservation of essential functions
of BgMIF that enable it to regulate the immune response in this
invertebrate.
BgMIF thus presents conserved activities of the MIF family and
in order to address the question of its involvement in the innate
immune response we first determined its role in the interaction of
Bge cells with the sporocyst larvae of S. mansoni. We have
optimized the KD of BgMIF transcripts and showed for the first
time that the reduction of protein level was related to a resulting
phenotype in vitro. When Bge cells were stimulated with S. mansoni
ESP, they acquired an activated phenotype (aggregation) that was
no longer observed in cells treated with dsMIF. In addition we
showed that this aggregative phenotype was correlated with
phosphorylation of Bgp38, an activation known to promote cell
adhesion [33]. Using the in vitro co-cultivation system of Bge cells
and in vitro-transformed sporocysts [27], we observed that the KD
in BgMIF expression led to fewer Bge cells migrating towards and
encapsulating the sporocysts, resulting in a lower percentage of
encapsulated sporocysts than observed in control conditions.
These results suggest that BgMIF is intimately involved in the
response of the snail to parasites.
We next performed BgMIF KD in vivo using the microinjection
of dsRNA previously described for B. glabrata snails [47] and
analyzed its consequences on the hemocyte population of snails
exposed to infection by S. mansoni miracidia. After 24 h following
infection, the population of circulating hemocytes in non-
interfered snails showed a marked reduction in the number of
large cells (granulocytes), which, together with hyalinocytes, form
the heterogeneous hemocyte population present in healthy snails
[25]. This decrease in circulating granulocytes is due to their
mobilization by the parasites and their migration towards the
invaded tissues [35], [36]. When we examined the hemocyte
populations of infected dsMIF-treated snails, we did not observe
such a reduction in the number of granulocytes, suggesting that
BgMIF is necessary for hemocyte activation during the in vivo
response to the parasite. This change in the behavior of hemocytes
was accompanied by a significant increase in the number of
sporocysts establishing in dsMIF-treated snails, underlining the
importance of MIF in regulating the innate immune response
toward the parasite. The absence of hemocyte activation may be
due to the lack of a signal generated by BgMIF released under
normal conditions. It has been demonstrated that MIF deficient
macrophages are hyporesponsive to stimulation by LPS or Gram-
negative bacteria stimulation and that this is due to TLR4
downregulation [48]. In dsRNA-treated snails we also showed that
the absence of hemocyte migration correlated in these cells with a
down regulation of a Toll receptor ortholog, BgToll1, which we
have recently identified (unpublished data). These data suggest
that the BgToll1 expression may be regulated by BgMIF and that
BgMIF facilitates the activation of hemocytes and their migration
towards invaded tissues.
Taken together, the results presented here demonstrate the
involvement of BgMIF in the innate immunity of B. glabrata. This
is the first functional study of a molecule involved in the regulation
of the anti-parasite response in B. glabrata, and the tools developed
here pave the way towards a better understanding of the complex
interactions between medically important helminths and their
molluscan snail hosts.
Materials and Methods
Ethics statement
All animal experimentation was conducted following the Nord-
Pas de Calais Region and the Pasteur Institute of Lille guidelines
for housing and care of laboratory animals and performed in
accordance with institutional regulations after review and approval
by the Nord-Pas de Calais Region (Authorization No. A59-35009)
and Pasteur Institute (Authorization No. AF/2009) Animal Care
and Use Committees.
Animals and cells
Adult (6–10 mm in diameter) B. glabrata snails (albino strain),
were raised in pond water and fed ad libitum. A Puerto-Rican strain
of S. mansoni was maintained by passage through B. glabrata snails
and Mesocricetus auratus. Miracidia were isolated from infected
hamster livers and maintained in complete Chernin’s balanced salt
solution [49] (CBSS supplemented with 1 mg/ml glucose and
1 mg/ml trehalose) for 48 h to achieve in vitro transformation into
mother sporocysts as described in [50]. Mother sporocysts and/or
excretory-secretory products (ESP)-containing CBSS were then
collected and used. The B. glabrata embryonic (Bge) cell line
(ATCC CRL 1494; Rockville, MD), was maintained at 26uC
under normal atmospheric conditions in complete Bge medium
[51], supplemented with 10% fetal bovine serum (FBS; Sigma),
and antibiotics (100 U/ml penicillin G; 0.05 g/ml streptomycin
sulphate, 25 mg/ml amphotericin B, Sigma).
RNA, cDNA and protein extraction
Total RNA and protein from individual snails was extracted
using the TRIZOL reagent (Invitrogen) according to the
manufacturer’s instructions. Total RNA from Bge cells was
extracted using the Rneasy Mini kit (Qiagen) according to the
manufacturer’s instructions. For hemocytes the collected hemo-
lymph [52] was divided in two tubes for extraction of protein and
for extraction of RNA. For cDNA synthesis, RNA from whole
snails (1 mg) and Bge cells (0.1 mg) were used for reverse
transcription using SuperScript III reverse transcriptase (Invitro-
gen) and the oligo(dT)20 primer.
Molecular cloning of BgMIF and vectors
A partial cDNA sequence (EST GenBank accession number:
CK989824[21]) was used to design specific primers and perform
59 and 39 RACE amplification (SMART RACE cDNA Amplifi-
cation kit, Clontech) according to the manufacturer’s instructions.
The complete BgMIF coding sequence was then amplified using
primers containing XhoI and XbaI restriction sites respectively
(see Supplementary data Table S1 for primer sequences). The
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PCR products were digested and cloned into the bacterial
expression vector pET303 Ct-His (Invitrogen) (BgMIF construct).
A BgMIF mutant construct (P2G pET303 Ct-His) was generated
by site directed mutagenesis using primers (Supplementary data
Table S1) encoding glycine instead of proline after the initiating
methionine (BgMIFP2G construct). Sequence alignments and
analysis were carried out using the DNAStar Lasergene pro-
gramme package and the BioEdit v7.0.1 package (http://www.
mbio.ncsu.edu/BioEdit/bioedit.html).
For phylogenetic analysis, multiple amino acid sequence
alignments were performed using MUSCLE [53] or 3DCoffee
[54]. The maximum likelihood tree was obtained with PhyML 3.0
[55] or MrBayes [56] at LIRMM (http://www.phylogeny.fr/)
using the WAG model of substitution with four substitution rate
categories and estimated gamma shape parameter and proportion
of invariant sites. Branch support values were based on 500
bootstrap replicates with PhyML or 100000 replicates for
MrBayes.
Protein expression and production of recombinant
proteins
Recombinant C-terminally His-tagged full-length rBgMIF and
rBgMIFP2G fusion proteins were expressed using the pET303 Ct-
His vector in E. coli BL21 (DE3) pLys strain. One liter of bacterial
culture was grown to an OD600 nm of 0.4 and induced by addition
of isopropyl b-1-D-thiogalactopyranoside to a final concentration
of 0.4 mM. After 3 h at 30uC, cells were harvested, lysed and
purified with Ni-NTA agarose resin (Qiagen) according to the
manufacturer’s instructions. Briefly, cells were resuspended in lysis
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole) and
disrupted by successive freeze-thaw cycles in liquid nitrogen. The
soluble protein fraction was mixed with Ni-NTA agarose and
incubated under agitation for 1 hour at 4uC. The resin was then
washed (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole)
and finally tagged proteins were eluted with 50 mM NaH2PO4,
300 mM NaCl, 200 mM imidazole. The purified protein was
dialyzed against endotoxin-free PBS overnight and the content of
remaining endotoxin was measured with Limulus Amoebocyte
Lysate (Cambrex). Recombinant proteins used in the bioassays
contained less than 200 pg endotoxin/mg of protein.
Enzymatic assay
Tautomerase activity was measured using a D-dopachrome
tautomerase assay as described previously [14], [22]. Briefly, a
fresh solution of D-dopachrome methyl ester was prepared by
mixing 4 mM L-3,4-dihydroxyphenylalanine methyl ester with
8 mM sodium periodate for 5 min at room temperature that was
then placed on ice 20 min before use. Activity was determined at
room temperature by adding D-dopachrome methyl ester to a
cuvette containing 50 mM rBgMIF, BgMIFP2G or a commercial
mammalian MIF (mouse MIF), rMmMIF (R&D systems), in
25 mM potassium phosphate buffer pH 6.0 and, 0.5 mM EDTA.
For the inhibition assays the MIF inhibitor, (S,R)-3-(4-hydro-
xyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1,
Merck) was dissolved in Me2SO at various concentrations and
added to the cuvette with rBgMIF prior to the addition of the
dopachrome. The decrease in absorbance at 475 nm was
monitored for 5 min using a UV/visible Spectrophotmeter
Ultraspec 2100 (Amersham).
Antibodies and Western-blots
Antibodies used in this study were as follows: anti-Actin
(Abcam), anti-phospo-p53Ser15, anti-phospho-p44/42 MAPK
(Erk1/2) (Thr202/Tyr204), anti- p44/42 MAPK (Erk1/2) and
anti-Phospho-p38 MAPK (Thr180/Tyr182) (Cell Signaling). An
anti BgMIF antiserum was produced in a rabbit using the
Ac-HKDITEIASEFLQKSQK-amide, Ac-VRVPALFCQFDG-
HLHGH-amide peptides and the polyclonal sera were purified
using a peptide linked resin column (Proteogenix). For western blot
analysis cells or snails were lysed in Tris-buffered saline (50 mM
Tris-Base, 150 mM NaCl, pH 7.5) containing 1% NP-40, 0.5%
deoxycholic acid, 0.1% SDS, 2 mM EDTA, and 1 mM PMSF),
cellular debris was pelleted and the supernatants were adjusted for
protein concentration and diluted with reducing SDS-PAGE sample
buffer. For BgMIF analyses the total protein extracts were separated
by SDS-PAGE in pre-cast 16% tricine gels (Invitrogen) and
transferred to a PVDF membrane with 0.2 mm pore size (Millipore).
For actin, ERK, p38 and p53 analyses the total protein extracts were
separated by SDS-PAGE Tris-glycine gels and transferred to a
PVDF membrane with 0.45 mm pore size (Millipore). Western blot
analyses were then performed using the SNAP id system (Millipore)
according to the manufacturer’s instructions.
Expression studies
For real-time PCR analyses total RNA (1 mg of RNA from a 5
snail pool and one tenth of the RNA obtained from 26105 Bge
cells or collected haemocytes) was reverse transcribed using
SuperScript III reverse transcriptase (Invitrogen). For Q-PCR
analyses, cDNAs used as templates were amplified using the SYBR
Green Master Mix (Invitrogen) and the ABI PRISM 7000
sequence detection system (Applied Biosystems). Primers (Sup.
Table 1) specific for B. glabrata ribosomal protein S19 (Genbank
accession number CK988928;[21]), and BgMIF, were designed by
the Primer Express Program (Applied Biosystems) and used for
amplification in triplicate assays.
The organ distribution of BgMIF protein was determined in adult
snails. Organs (albumen gland, hepatopancreas, foot, heart and
digestive tract) were excised, sectioned and homogenized at 4uC
with Tris-buffered saline. The cellular debris was pelleted and the
supernatants were adjusted for protein concentration, diluted with
reducing SDS-PAGE sample buffer and 15 mg of total protein was
analyzed by SDS-PAGE and western blotting as described above.
For the measurement of BgMIF protein contained in the plasma
(cell free hemolymph) after infection we used an indirect ELISA
protocol. Briefly, the cell hemolymph for five snails was pooled and
centrifuged to pellet the cells. Wells of a PVC microtiter plate were
coated with 100 ml of hemolymph diluted by half in PBS and
plates were incubated for 2 h at room temperature. Then, after the
coating solution was removed, plates were washed three times by
filling the wells with 200 mL of PBS. The solutions or washes were
removed by flicking the plate over a sink. The remaining protein
binding sites in the coated wells were blocked by adding 200 mL of
blocking buffer (5% bovine serum albumin (BSA) in PBS) per well.
Plates were covered and incubated for 2 h at room temperature.
Plates were then washed twice with PBS, and 100 mL of anti-MIF
antibody (from rabbit, diluted 1/500, Proteogenix) diluted in
blocking buffer was added to each well. Plates were covered and
incubated overnight at 4uC. Subsequently, plates were washed
four times with PBS, and 100 mL of conjugated secondary
antibody (antirabbit, diluted 1/5000, Jackson Immuno Research)
diluted in blocking buffer was added to each well. Then, plates
were covered and incubated 2 h at room temperature. After four
washes, the horseradish peroxidase (HRP) activity was measured
using the colorimetric substrat TMB (3,3–5,5 –Tetramethylbenzi-
dine) blue substrate (Roche Applied Science). A standard with
rBgMIF ranging between 0–230 ng/ml was used. The measure-
ments were made twice in triplicate with two different infection
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experiments using a microplate reader MRXII (Dynex Technol-
ogies) at 450 nm; the haemolymph was pooled before infection
and 6, 24 and 48 h post infection.
Immunolocalisation of MIF in cells
For immunolocalisation assays, circulating haemocytes or Bge
cells were extracted or cultured as described above and allowed to
adhere to glass slides, washed with PBS, fixed in 4% paraformal-
dehyde for 10 min and permeabilised by a 4 min treatment with
Triton X-100 at 0.1%. Slides were saturated for 90 min with PBS
containing 1% bovine serum albumin (BSA) and normal goat
serum (1/50) at room temperature (RT). This blocking step was
followed by an overnight incubation with rabbit anti-BgMIF
polyclonal serum (diluted at 1/100 in PBS-BSA 1%). After three
washes the slides were incubated with goat anti-rabbit Alexa Fluor
488 IgG (1/500 in PBS-BSA 1%, Molecular Probes) for 2 h at
room temperature (RT). Slides were then stained with Hoechst
33342 and rhodamine-labeled phalloidin (1/1000 in PBS, Sigma)
for 10 min at RT, washed and mounted with Fluoromont G
(Interchim). For control slides, anti-BgMIF polyclonal serum was
incubated with the peptides used as immunogens for 1 h at RT
and the slides were then treated as described above. Samples were
analysed by confocal microscopy using a LSM 710 inverted
microscope (Zeiss).
Confocal microscopy
All the confocal imaging was performed with a LSM710
microscope (Zeiss) and a Plan Apochromat objective (6361.4 NA
oil immersion). The associated software (Zen 2008) enabled the
adjustment of acquisition parameters. The rhodamine (red) signal
was excited at 561 nm and emission was collected from 570 to
700 nm. The Alexa488 (green) signal, in contrast, was excited at
488 nm and emission was collected from 490 to 530 nm. The
nuclear Hoechst dye signal was excited at 405 nm and emission
was collected from 410 to 470 nm. Fluorescent signals were
collected sequentially, with a 4 lines average, and resulting images
are 204862048 (or 102461024) pixels in size. By setting the
photomultiplier tubes and the pinhole size (1 AU) correctly, there
was no signal bleed-through. The images were treated with ImageJ
(NIH) and Photoshop CS3 (Adobe).
Proliferation and ERK MAPK activation studies
The protocol used was adapted from [29]. Briefly Bge cells
(26104 cells/well) were cultured until semi-confluent in 96-well
plates in complete Bge medium. The cells then were synchronized
by culture in 0.5% FCS-containing Bge medium overnight. The
medium was then replaced by fresh medium (control condition) or
medium containing different concentrations of rBgMIF. After
incubation with rBgMIF the cells were pulsed with 10 mM of BrdU
(Sigma) for 2 h and the proliferation was measured by ELISA
method as described in [57]. In order to test the effect of inhibition
of the ERK pathway, cells were treated with the MEK inhibitor
U0126 (Cell Signalling) at 10 mM or Me2SO (solvent) for 30 min
prior to the addition of rBgMIF and were then treated as above.
For analysis of sustained activation of ERK, cells (26105cells/
well) were cultured and synchronized as described above. Cells were
exposed to various concentrations of rBgMIF, for 2 h, 8 h and 24 h,
and then lysed as described above. Cell lysates were used for western
blot analysis of phosphorylated and total ERK content.
Apoptosis assay
The apoptosis assay used was adapted from [31]. Bge cells
(semi-confluent) were cultured in 6-well plates in complete Bge
medium. Cells were pretreated for 12 h with rBgMIF at different
concentrations. The NO donor, S-nitrosoglutathione (SNGO,
Sigma) was then added at 250 mM for 8 h. Apoptosis was
measured by the Terminal deoxynucleotidyl transferase mediated
dUTP Nick End Labeling (TUNEL) assay (Roche Applied
Biosystems), following the manufacturer’s instructions. Briefly,
the cells were fixed in paraformaldehyde 4% for 1 h, washed and
permeabilized with sodium citrate 0,1%/Triton -X 100 0.1% for
2 min on ice. Cells were incubated with ‘‘labeling solution’’ for 1 h
at 37u C, washed with PBS and the number of positive cells was
visualized on a FACSCalibur flow cytometer (Becton Dickinson)
and the data were treated with CellQuestPro software (Becton
Dickinson). The data are displayed using a logarithmic scale and
the results are represented as the percentage of cells undergoing
apoptosis. Activation of p53 was investigated by performing a
western blot on total protein extracts from Bge cells using the anti-
p53ser15P antibody and the anti-actin antibody.
Production of dsRNA
PCR products were amplified from the pCR2.1 TOPO vector
containing the complete BgMIF sequence, purified (Wizard SV
Gel and PCR Clean up system, Promega) and used as a template
for T7 transcription and synthesis of BgMIF dsRNA (MEGA-
Script T7 kit, Ambion). The firefly (Photinus pyralis) luciferase gene
dsRNA (pGL3 vector, Promega) was used as a control (see Sup.
Table 1).
Stimulation of Bge cells with S.mansoni ESP
Bge cells (26105cells/well) were cultured in 12-well plates in
complete Bge medium. For the analyses of BgMIF excretion the
medium was changed for complete CBSS and the cells were
stimulated with different quantities (30, 60, 120, 240 and 480 mg/ml
of protein content) of S. mansoni ESP (prepared as described in [33])
for 12 h. Cell supernatants were collected, centrifuged for 10 min at
800 g to eliminate non adherent cells, then concentrated 10-fold by
membrane filtration with a 10 kDa cut-off (Centricon, Amicon). For
the study of Bgp38 activation, the protocol was adapted from [33].
Briefly, cells were exposed to 120 mg/ml of ESP for 5, 15 and
30 min, and the protein extracts were analysed for the phosphor-
ylated p38 and actin content by western blotting. The content
of endotoxin was measured with Limulus Amoebocyte Lysate
(Cambrex). ESP used in the bioassays contained less than 17 pg
endotoxin/mg of protein.
RNA interference assays in Bge cells
Each dsRNA (2 mg) was transfected into confluent cultures of
Bge cells using the FUGENE HD transfection reagent (Roche
Applied Biosystems), following the manufacturer’s instructions.
For the experiments with EPS, the Bge medium was changed to
complete CBSS 2 days after the addition of dsRNA. On the third
day 120 mg/mL of ESP products were added to the medium and
the presence or absence of an aggregation phenotype was
determined. For encapsulation experiments, the medium was
replaced by fresh medium and S. mansoni mother sporocysts
cultured in complete CBSS for 48 hours, were added (500
sporocysts/well) 3 days after the addition of dsRNA. The co-
culture was maintained 4 days to allow the observation of an in
vitro encapsulation phenotype as described previously [50].
Aggregation and encapsulation phenotypes were observed using
an Eclipse TS100 optical microscope (Nikon) and the images were
acquired with a DS-Fi1digital camera (Nikon) and treated with
Photoshop CS3 (Adobe). For encapsulation experiments, 250–300
sporocysts were counted per assay and the results were represented
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as the percentage of sporocysts completely covered in adhering
cells.
RNA interference assays in whole snails and FACS
analysis
Each dsRNA (15 mg in 10 ml of sterile CBSS) was injected into
the cardiac sinus of B. glabrata snails, using a 50 ml Hamilton
syringe with a 26s needle (Hamilton). Three days after injection,
hemocytes were isolated from three snails per group and the snails
were individually frozen in liquid nitrogen for extraction of RNA
and soluble protein. Knock down efficiency was checked by real-
time PCR and western blot analyses. Snails were infected three
days after injection, with 20 S. mansoni miracidia. 24 h post
infection the hemolymph of three snails was pooled and diluted by
half in complete CBSS containing citrate/EDTA (50 mM sodium
citrate, 10 mM EDTA, and 25 mM sucrose) [58] and the
composition of the hemocyte population in each condition was
assessed by FACS analyses using SSC and FSC parameters in a
FACSCalibur flow cytometer (Becton Dickinson). The hemocyte
population was analyzed in pools of three snails.
In order to determine the number of mother sporocysts (Sp1)
present in the head–foot region of infected snails, mollusks were
fixed 15 days post-exposure as described [59], [60]. Briefly, the
snails were relaxed in water containing an excess of crystalline
menthol for 6 h. The snail shell was removed and the body was
fixed in modified Raillet–Henry’s solution (930 ml distilled water,
6 g NaCl, 50 ml Formol 40%, 20 ml acetic acid). The head–foot
zone was dissected and visually inspected. In each snail Sp1 were
readily observable as translucent white bodies within an opaque
yellow tissue background.
Statistical analyses
All data were expressed as mean plus or minus SE. The
statistical significance of differences was assessed using the Mann–
Whitney U test for nonparametric data or Student’s t-test using the
program StatView (Abacus Concepts). P values of less than .05,
0.01 or .001 were used to indicate statistical significance.
Accession numbers
Nucleotide sequence data reported in this paper are available in
the GenBank database under the accession numbers ACR81564
(BgMIF), GU929337 (Bgp53).
Supporting Information
Figure S1 MIF antagonist ISO-1 inhibits BgMIF D-dopa-
chrome tautomerase activity. Analysis of the D-dopachrome
tautomerase enzymatic activity measured as the loss in absorbance
at 475 nm and plotted against the concentration of 2-carbox-
ymethylester-2,3-dihydroindole-5,6-quinone for 50 nM wild type
rBgMIF in presence of ISO-1. Results shown are the means +/2
S.D. of three independent experiments.
Found at: doi:10.1371/journal.ppat.1001115.s001 (0.09 MB TIF)
Figure S2 BgMIF concentrations in snail plasma decrease after
S. mansoni infection. After 0 h, 6 h, 24 h and 48 h infection by
S. mansoni miracidia BgMIF levels in snail plasma were quantified
by indirect ELISA tests. Results are the means +/2 S.D. of
the triplicate of two different infection experiments (*p,0,05;
**p,0,001).
Found at: doi:10.1371/journal.ppat.1001115.s002 (0.09 MB TIF)
Figure S3 The MEK inhibitor U0126 prevents the stimulatory
effect of BgMIF on Bge cell proliferation. The proliferation rate of
Bge cells treated with 10 mM of U0126 or DMSO (solvent) was
measured in the presence of various concentrations of rBgMIF.
Proliferation was assessed using BrdU incorporation measured by
an ELISA assay. Results are represented as fold increase in BrdU
incorporation as compared to incorporation in control cells. The
results shown are the mean 6 SD of two assays carried out in
quadruplicate and are representative of 3 separate experiments
*p,0,05.
Found at: doi:10.1371/journal.ppat.1001115.s003 (0.14 MB TIF)
Table S1 Oligonucleotide primers used in the study.
Found at: doi:10.1371/journal.ppat.1001115.s004 (0.04 MB
DOC)
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